In selecting California Attorney General Xavier Becerra as his HHS secretary nominee, President-elect Joe Biden has signaled his intention to follow through on campaign commitments to extending the Affordable Care Act and giving Medicare the...

Four former FDA officials and an oncologist are on a list of candidates President-elect Joe Biden’s team is considering as FDA commissioner, individuals who are advising the transition team told BioCentury....

While the outcome of Tuesday’s elections may not be known for some time, it is certain that there will be changes in the leadership and composition of a Senate committee that shapes the life sciences...

The increasing likelihood of a contested U.S. presidential election means the markets could be in for a high dose of volatility in 4Q20, pushing the pause button on a record year for IPOs and sending...

Senate Health, Education, Labor and Pensions Committee Chairman Lamar Alexander (R-Tenn.) announced Wednesday that he plans to fast-track confirmation of Stephen Hahn as FDA commissioner. The committee will vote on Hahn's confirmation on Dec. 3...

The path to Stephen Hahn’s confirmation as FDA commissioner is enveloped in clouds of flavored vapor, littered with piles of Impossible Burgers, and passes tanks filled with precocious fish. The Trump administration’s policies on regulating...

Heading into the third quarter, specialist biotech investors are in the driver’s seat, and their stances on whether to trim or spend in the down market are split. After recovering at the start of the...

A scathing letter from Sen. Richard Durbin (D-Ill.), the Democratic Whip, expressing a lack of confidence in acting FDA Commissioner Ned Sharpless could cloud chances for Sharpless to be nominated or confirmed as permanent commissioner....

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) said its shareholders re-elected all three of its preferred board director nominees during its annual shareholder meeting. Alex Denner, who holds about a 2.2% stake in Ironwood and is chief investment...

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) said its shareholders re-elected all three of its preferred board director nominees during its annual shareholder meeting. Alex Denner, who holds about a 2.2% stake in Ironwood and is chief investment...